Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021

SELL
$3.93 - $5.5 $342,023 - $478,659
-87,029 Closed
0 $0
Q3 2020

Nov 04, 2020

BUY
$4.01 - $5.56 $1,604 - $2,224
400 Added 0.46%
87,029 $349,000
Q2 2020

Jul 17, 2020

SELL
$3.0 - $5.52 $5,775 - $10,626
-1,925 Reduced 2.17%
86,629 $398,000
Q1 2020

Apr 21, 2020

SELL
$2.54 - $4.75 $23,037 - $43,082
-9,070 Reduced 9.29%
88,554 $289,000
Q3 2019

Nov 07, 2019

BUY
$3.83 - $4.72 $373,899 - $460,785
97,624 New
97,624 $384,000
Q3 2017

Oct 26, 2017

SELL
$2.91 - $4.71 $30,071 - $48,673
-10,334 Closed
0 $0
Q2 2017

Aug 15, 2017

BUY
N/A
10,334
10,334 $39,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $401M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.